Dr Joanne Hildebrand
Honorary (Fellow)
Department of Medical Biology (WEHI)
51 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
The kinase domain of RIPK3 tunes its scaffolding functions
DOI: 10.1038/s41418-026-01677-x2025
Journal article
Lipid nanoparticle-delivered intrabodies for inhibiting necroptosis and pyroptosis
DOI: 10.1042/bcj202531912025
Journal article
Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice
DOI: 10.26508/lsa.2023024462024
Journal article
MLKL deficiency elevates testosterone production in male mice independently of necroptotic functions
DOI: 10.1038/s41419-024-07242-z2024
Journal article
An immunohistochemical atlas of necroptotic pathway expression
DOI: 10.1038/s44321-024-00074-62024
Journal article
Defining a Water-Soluble Formulation of Arachidonic Acid as a Novel Ferroptosis Inducer in Cancer Cells
DOI: 10.3390/biom140505552024
Journal article
Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation
DOI: 10.1042/BCJ20240255
RECENT SCHOLARLY WORKS
2023
Journal article
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation
DOI: 10.1038/s41467-023-41724-62023
Journal article
Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization
DOI: 10.1038/s41467-023-42255-w2023
Journal article
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase
DOI: 10.1042/BCJ20230035